E223: From Population Models to Personal Intelligence: Rethinking Biological Data
About this episode
Dr Andree Bates discusses the shift from population models to personal intelligence in biological data with Ken Clark of Enigma Genetics.
For most of modern medicine, biological data has been built around population averages: what people like you might experience, rather than what you personally will. In this episode, Dr Andree Bates speaks with Ken Clark, co-founder and CEO of Enigma Genetics, about moving from population models to personal intelligence, and what it could mean for patients, pharma and the future of biological data. Ken shares the personal medical experience that led him into this work. After multiple surgeries and a persistent infection, he found that the data needed to understand what had changed in his own biology simply wasn’t available in a useful way. That sparked the idea of creating a personal biological “version history”, a healthy baseline that can be compared against future changes as science and computation improve. The conversation explores Enigma Genetics’ vision for an AI that lives within a personal health profile, continuously aggregating genetic data, medical records, imaging, wearables and other health information to help build the most comprehensive picture possible for the individual and their doctor. The goal is not to replace medical judgement, but to give clinicians a…
More episodes of AI For Pharma Growth
- E226: The AI Deal Scout: How Machine Intelligence Is Reshaping Biopharma Business Development
- E225: The 80% Nobody Talks About: Building AI Governance That Survives a Pharma Audit
- E224: The Diagnostic Room: The Financial Case Your CFO Actually Needs to See Before Approving Your AI Strategy
- E222: Why Most Pharma AI Will Fail Without This One Thing
Explore listener stats, chart rankings, contacts and more on the AI For Pharma Growth podcast page.